Cedars-Sinai investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the blood-brain barrier. This combined stem cell and gene therapy can potentially protect diseased motor neurons in the spinal cord of patients with amyotrophic lateral sclerosis, a fatal neurological disorder known as ALS or Lou Gehrig's disease.
In the first trial of its kind, the Cedars-Sinai team showed that delivery of this combined treatment is safe in humans.
- Read more about Stem Cell-Gene Therapy Shows Promise in ALS Safety Trial
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2022/stem-cell-gene-therapy-shows-promise-in-als-safety-trial
No comments:
Post a Comment